Skip to main content
Signal8

VINCENT RICHARD G

SEC insider (Form 3/4/5 filer). CIK 0001269341. Director at Forte Biosciences, Inc. (FBRX). 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 27, 2026. Located in DALLAS, TX.

Companies VINCENT RICHARD G has filed insider reports for

  • Forte Biosciences, Inc. (FBRX): Director
VINCENT RICHARD G profile photo

VINCENT RICHARD G

CIK: 0001269341

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)3 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Forte Biosciences, Inc. logo
FBRX

Forte Biosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • Forte Biosciences, Inc. logo
    FBRX

    Forte Biosciences, Inc.

    Aug 27, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    2K shares-
  • Forte Biosciences, Inc. logo
    FBRX

    Forte Biosciences, Inc.

    Aug 27, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    31K shares-
  • Forte Biosciences, Inc. logo
    FBRX

    Forte Biosciences, Inc.

    Aug 27, 2026
    Disposition

    Restricted Stock Units

    Direct
    18.4K shares-
  • Forte Biosciences, Inc. logo
    FBRX

    Forte Biosciences, Inc.

    May 29, 2026
    Award

    Restricted Stock Units

    Direct
    18.4K shares-
  • Forte Biosciences, Inc. logo
    FBRX

    Forte Biosciences, Inc.

    Mar 20, 2025
    Award

    Stock Option (right to buy)

    Direct
    31K shares-
  • Forte Biosciences, Inc. logo
    FBRX

    Forte Biosciences, Inc.

    Sep 17, 2024
    Award

    Stock Option (right to buy)

    Direct
    2K shares-

1-6 of 6